surmount-1 tirzepatide SURMOUNT Clinical Trials Orals Session Articles & Evidence Briefings |

Patients should be aware that: Compounded medications have different liability protections Insurance may not cover adverse events from non-FDA-approved medications Legal recourse may be limited if problems occur State regulations for compounding pharmacies vary The Bottom Line on Safety and Effectiveness Both Mounjaro and compounded tirzepatide contain the same active ingredient, but thats where the similarities end

Both drugs also carry a black box warning that they may increase the risk of thyroid C-cell tumors

Based on studies with other GLP-1 receptor agonists, these medications may enhance sodium excretion in renal tissues, potentially leading to mild diuresis

Given the availability of alternatives, exposing pregnant women and fetuses to this uncertainty is not justified

Follicles are more vulnerable to low protein intake and deficiencies in: Iron Ferritin Vitamin D Zinc Biotin High stress from illness or changes in routine can add to shedding